About a year ago, after Sen. Brown won election in Massachusetts, and it seemed like health care reform would die, I began to despair at
3 interesting articles in JAMA today: Bad news for Roche. Avastin (bevacizumab) is associated with increased treatment-related mortality, according to a meta-analysis of 16 RCTs
If one wants to address the problems in health insurance markets and/or to get providers to accept payment reforms, the mandate–or something like it–is the
A very good question from Brad F., a TIE reader: If a district court in FL has a state participating in a suit, say WI,
Aaron and I are very interested in an honest, good-faith, evidence-based dialog on how to reform our health system. In order to make progress, we
If you missed my last two posts on cost shifting theory, you might want to read them (part 1, part 2). This post does stand
the health services research blog
Work posted here under copyright © of the authors • Details on the Site Policies page
